According to a statement issued by Griffin Hospital, patients may have been put at risk for disease transmission due to misuse of insulin pens.

According to the hospital, insulin pens may have been used on more than one patient between Sept. 1, 2008 and May 7, 2014. This could potentially put patients at risk for contracting serious diseases such as hepatitis B, hepatitis C and HIV.

According to reports, at least five nurses at the hospital admitted to using insulin pens on multiple patients. While there is no evidence of needle sharing, when insulin pen’s cartridges are shared, patients may be at risk for contracting disease via contamination through the backflow of blood or skin cells from another patient.

“(W)e discovered that in a small number of cases, multi-dose insulin pen cartridges intended for single patient use may have been used for more than one patient,” the hospital said in a letter to patients. “Upon learning this, we stopped using this type of insulin pen to avoid any further potential for improper use.”

The hospital is testing patients who could potentially be at risk for hepatitis B, hepatitis C and HIV and says patients should be tested within 30 days. More than 3,100 patients were ordered for patients at the hospital since Sept. 1, 2008.

This news is scary for many patients that may have been put at risk. Anyone who is diagnosed with a disease and who has been treated with insulin at Griffin Hospital will be eligible to sue for compensation. To learn more, contact the Connecticut medical malpractice lawyers at Berkowitz and Hanna LLC today.